Prestige Consumer Healthcare (NYSE:PBH) Reaches New 52-Week Low – Should You Sell?

Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) hit a new 52-week low during trading on Friday . The stock traded as low as $59.62 and last traded at $60.39, with a volume of 18436 shares traded. The stock had previously closed at $60.27.

Analyst Ratings Changes

PBH has been the subject of several research analyst reports. Zacks Research lowered shares of Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research report on Thursday, September 4th. Jefferies Financial Group cut their target price on Prestige Consumer Healthcare from $75.00 to $71.00 and set a “hold” rating on the stock in a research report on Monday, October 27th. Canaccord Genuity Group cut their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, October 8th. Finally, Oppenheimer cut their target price on Prestige Consumer Healthcare from $82.00 to $72.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 21st. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $87.33.

Prestige Consumer Healthcare Trading Up 0.6%

The stock has a market capitalization of $2.98 billion, a price-to-earnings ratio of 14.23, a P/E/G ratio of 1.93 and a beta of 0.44. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. The firm has a fifty day moving average of $63.63 and a 200-day moving average of $73.86.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The company had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. During the same quarter in the prior year, the company posted $0.90 earnings per share. The firm’s revenue for the quarter was down 6.6% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Norges Bank acquired a new position in Prestige Consumer Healthcare in the 2nd quarter worth $41,848,000. Kayne Anderson Rudnick Investment Management LLC grew its stake in shares of Prestige Consumer Healthcare by 45.3% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,580,819 shares of the company’s stock valued at $135,903,000 after acquiring an additional 493,199 shares in the last quarter. Invesco Ltd. grew its stake in shares of Prestige Consumer Healthcare by 24.7% during the first quarter. Invesco Ltd. now owns 1,321,800 shares of the company’s stock valued at $113,635,000 after acquiring an additional 261,537 shares in the last quarter. Tributary Capital Management LLC grew its stake in shares of Prestige Consumer Healthcare by 157.3% during the third quarter. Tributary Capital Management LLC now owns 379,410 shares of the company’s stock valued at $23,675,000 after acquiring an additional 231,969 shares in the last quarter. Finally, Edgestream Partners L.P. acquired a new stake in shares of Prestige Consumer Healthcare during the second quarter valued at about $10,821,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.